Search Results

Displaying Results 5201-5225 of 7558 "'RARE'"

Feb 09, 2026, 09:00 ET Pavo Fitness Unveils AI-Powered Smart Reformer on Kickstarter, Surpassing $650,000 Milestone

"Optimal Challenge Zone."Exclusive Kickstarter OpportunitiesThe campaign is currently live, offering "Movement Pioneers" a rare opportunity to secure the Pavo Reformer at exclusive Early Bird pricing—a significant discount from the planned MSRP. With the new Stretch Goal unlocked,

More news about: Pavo Fitness


Feb 09, 2026, 08:33 ET TheWell Bioscience Launches VitroPrime™ 3D Culture and Imaging Plate for Organoid and 3D Cell Culture Workflows

risk of structural damage, sample loss, and experimental variability—an especially costly challenge for organoid workflows, where samples are often rare, time-intensive to generate, and difficult to replace. These limitations make reliable long-term culture, high-resolution imaging, and laboratory automation

More news about: TheWell Bioscience Inc.


Feb 09, 2026, 08:30 ET 3 Key Trends Transforming the Future of Rare Disease Clinical Development, Upcoming Webinar Hosted by Xtalks

successfully advance rare disease clinical development and programs to drive meaningful change for patients. Join a Medpace rare disease expert as they explore key trends shaping the future of rare disease clinical development, including customizable platform trials, new technologies for rare diseases and new

More news about: Xtalks


Feb 09, 2026, 08:18 ET Behind the "Black Box;" As 2026 Rx Price Hikes Emerge, SHARx Exposes Specialty Drug Pricing

dispensing rules that are difficult to evaluate externally.The challenge is especially acute for patients who rely on specialty therapies for cancer, rare/genetic diseases, transplants, and other serious conditions, with limited or no alternatives—where administrative delays and inconsistent cost-sharing

More news about: SHARx


Feb 09, 2026, 08:00 ET INTURAI VENTURES ANNOUNCE FIRST ORDER SECURED WITH NORTH AMERICAN DEFENCE CONTRACTOR

agreement validates Inturai's defence market fit and directly supports the Company's strategic go-to-market objectives in North America.FFPS brings a rare combination of real-world Tier 1 combat experience and national-level credibility. The FFPS contracts to North American elite special operations units

More news about: INTURAI VENTURES CORP.


Feb 09, 2026, 03:30 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE

RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RARE during the class period listed are encouraged

More news about: DJS Law Group LLP


Feb 09, 2026, 03:25 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange

More news about: The Schall Law Firm


Feb 09, 2026, 03:01 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Lawsuit

global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the

More news about: THE ROSEN LAW FIRM, P. A.


Feb 09, 2026, 01:35 ET Automatic monitoring of brand counterfeits and protection for the factory - Lumene Group upgraded its cyber solutions to a new era

to find and fix potential vulnerabilities."Elisa's experts found the right solutions, and projects have been completed on schedule, which is rare for such large-scale IT projects," Pantsar says.Threat intelligence service monitors the internet for brand counterfeitsIn

More news about: Elisa Oyj


Feb 07, 2026, 14:33 ET Top 50 Cruise Ships Around the World for 2026 Revealed by TTW

AppealSeasonality plays a pivotal role in shaping the appeal of cruise itineraries. Cruises that align with optimal climate conditions, wildlife activity, and rare natural events outperform those on year-round routes. Voyages to destinations like Antarctica, the Arctic, Southeast Asia, and Japan are increasingly

More news about: Travel And Tour World


Feb 07, 2026, 11:00 ET WePlay Teams Up with "The Little Prince" to Launch 2026 Valentine's Day Special Activity, Creating a Romantic Social Media Feast for Young Americans

Launching specially designed, visually stunning Valentine's Day exclusive rings with dazzling effects.Little Prince Co-branded Gifts & Rare Items: Collaboratively designed a series of co-branded gifts and props that blend classic elements from the novel—roses, Planet B-612, and foxes.

More news about: WEJOY PTE. LTD.


Feb 06, 2026, 22:16 ET Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE), if they purchased or otherwise acquired the Company's shares between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"). This action

More news about: ClaimsFiler


Feb 06, 2026, 16:42 ET CGTN : les conversations de Xi Jinping avec Poutine et Trump le même jour soulignent le rôle de la Chine dans la stabilité mondiale

président chinois Xi Jinping s'est entretenu séparément avec le président russe Vladimir Poutine et le président américain Donald Trump mercredi, un rare tour de table diplomatique le même jour. CGTN a publié un article analysant les priorités des deux échanges de haut niveau et examinant le rôle croissant

More news about: CGTN


Feb 06, 2026, 16:15 ET Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton syndrome may be fatal in infancy with those living beyond a year having profound

More news about: Azitra, Inc.


Feb 06, 2026, 13:08 ET Atlanta Powerhouse Launches DOSSIER, A Design‑Led Luxury Real Estate Firm Offering a New Alternative Amid Brokerage Consolidation

excellence.With 17+ years of real estate experience complemented by a decade of global marketing leadership at The Coca‑Cola Company, Greene brings a rare combination of market expertise, brand strategy, design intelligence, and construction fluency. That perspective has been shaped further through years

More news about: Side; DOSSIER


Feb 06, 2026, 11:41 ET Berger Montague PC Investigating Claims on Behalf of Investors in Ultragenyx Pharmaceutical Inc. After Class Action Filing (NASDAQ: RARE)

Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) ("Ultragenyx" or the "Company") on behalf of investors who purchased Ultragenyx common stock during the period from August 3, 2023 through December

More news about: Berger Montague


Feb 06, 2026, 10:00 ET Beyond Games and Chatbots: Bonzu Defines a New Species of AI Companionship

Ally' Scarce in RealityReal-world relationships are fraught with variables and judgment. Bonzu's core companion offers something incredibly rare: unconditional alliance.The Unwavering AllyEven when you botch a mission in the Cyberpunk zone and the world turns against

More news about: Bonzu


Feb 06, 2026, 10:00 ET Folger Theatre Announces Cast and Creative Team for William Shakespeare's "As You Like It"

Factory: Hamlet; Baltimore Center Stage: Dream Girls; ArtsCentric: The Wiz, Aida, Memphis, Little Shop of Horrors. Film: Finding Hero, Very Rare, The Infection, For Sale By Exorcist. Tours: Cahoots Theatre: The Vanishing Elephant. Training: University of Southern Mississippi, BFA. @teeerranceAhmad

More news about: Folger Shakespeare Library


Feb 06, 2026, 09:08 ET Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers' hands

said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk. "We chose to show up at the big game because it gives us a rare chance to speak to so many people at once—to cut through clutter and start honest conversations about weight for people who want to take a step toward

More news about: NOVO NORDISK INC.


Feb 06, 2026, 09:00 ET Hape and The Metropolitan Museum of Art Unveil Art-Inspired Toy Collection at New York Toy Fair 2026

Cloisters. Millions of people also take part in The Met experience online. Since its founding, The Met has always aspired to be more than a treasury of rare and beautiful objects. Every day, art comes alive in the Museum's galleries and through its exhibitions and events, revealing both new ideas and unexpected

More news about: Hape Toys


Feb 06, 2026, 08:49 ET RARE Investor Alert: Faruqi & Faruqi, LLP Reminds Ultragenyx (RARE) Investors of Securities Class Action Deadline on April 6, 2026

leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc ("Ultragenyx" or the "Company") (NASDAQ: RARE) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed

More news about: Faruqi & Faruqi, LLP


Feb 06, 2026, 06:59 ET Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line

Pharmaceuticals' branded generic portfolio. It also underscores our commitment to providing treatment options for patients and families affected by rare conditions.Emflaza® is a registered trademark of PTC Therapeutics, Inc.INDICATIONPYQUVITM is a corticosteroid

More news about: Aucta Pharmaceuticals, Inc.


Feb 06, 2026, 04:25 ET Resume.org Survey: AI Slop Crisis: 7 in 10 Managers Report Recurring, Costly Errors from Direct Reports' AI Use

exceeding $50,000. AI-related mistakes are widespread and impact most organizations. The data reveals that these errors are far from rare, with 70% of managers witnessing at least one AI-related mistake in the past year. Notably, these incidents are often recurring: 12% reported seeing

More news about: Resume.org


Feb 06, 2026, 02:12 ET Japonisme Reignites in Tokyo's Mukojima: A New Cultural Experience Invites Visitors to Walk, Print, and Take Home the World of Hokusai

interest in Japanese culture. Located within walking distance of two of Tokyo's most popular destinations—Asakusa and Tokyo Skytree—the program offers a rare opportunity to enjoy a calm, historically preserved district where Edo-era atmosphere and living craftsmanship coexist. Tourism Media Service spoke

More news about: Tourism Media Service


Feb 06, 2026, 02:01 ET MREO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Mereo BioPharma Group plc

Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases.

More news about: Robbins LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.